The potential of spray drying is being explored widely in the pharmaceutical industry. Since spray drying is a fast and very gentle way to produce free-flowing powders and a process that allows for a very precise particle formation, it can be applied for several purposes: to increase the bioavailability of a drug, for controlled release or taste masking, for aseptic production and to produce fine powders for inhalation or other applications.
GEA Niro - the world leader in spray drying technology - is in the forefront of Pharmaceutical Spray Drying. The GEA Niro Pharma Test Station - one of the world's most advanced cGMP spray drying facilities - is available for clients to explore the technology. "We can assist clients in developing the optimum spray drying processes for pharmaceuticals and pharmaceutical grade products and produce samples for safety, stability and toxicology studies and of Clinical Trials Materials", says Michael Wahlberg, head of the GEA Niro Test Center in Denmark.
On 16 - 19 February, GEA Process Engineering Inc. - GEA Niro in the US - will be participating at the US Informex trade show in San Francisco to promote the technology. Here, company representatives will be available to provide more insights into pharmaceutical spray drying and discuss how working with GEA Process Engineering and GEA Niro helps clients exploit the full potential of the technology.
About GEA Niro
GEA Niro is the world leader in spray drying technology and has a long history of serving the pharmaceutical industry. The supply includes laboratory scale spray dryers for R&D and spray dryers for full-scale production under cGMP conditions. GEA Niro also offers assistance with spray drying process development and cGMP contract spray drying. The expertise includes technologies for processing API, excipients and solid dosage formulations by spray drying, agglomeration, encapsulation and spray congealing.
For more information, please visit www.niro.com
